Emergent BioSolutions | EBS - Денежные средства и эквиваленты





Денежные средства и эквиваленты Изменить Дата
Acadia Pharmaceuticals USD 851.46M 31.77M 2026-03
Akebia Therapeutics USD 162.64M 22.2M 2026-03
ALKERMES USD 511.53M 159.98M 2026-06
Alnylam Pharmaceuticals USD 1.71B 2.46M 2026-06
Amarin USD 143.56M 12.5M 2026-06
ANI Pharmaceuticals USD 311.18M 25.59M 2026-03
BioMarin Pharmaceutical USD 2.22B 910.76M 2026-03
Coherus Biosciences USD 88.88M 14.47M 2025-12
Emergent BioSolutions USD 111.7M 23.9M 2023-12
Exelixis USD 226.15M 256.34M 2026-03
Glaxosmithkline GBP 3.44B 146M 2026-03
Heron Therapeutics USD 26.12M 2.53M 2026-03
Ionis Pharmaceuticals USD 350.06M 1.57B 2026-06
Ironwood Pharmaceuticals USD 220.47M 5.01M 2026-03
Lexicon Pharmaceuticals USD 38.09M 3.76M 2026-03
Lonza CHF 719M 188M 2025-12
Merck USD 5.33B 9.24B 2026-03
Moderna USD 1.72B 185M 2026-06
Myriad Genetics USD 115.2M 9.2M 2026-06
Nektar Therapeutics USD 15.12M 25.92M 2025-12
Neurocrine Biosciences USD 332.4M 65.9M 2026-06
Pacira USD 144.31M 14.24M 2026-03
Pfizer USD 1.7B 561M 2026-03
PTC Therapeutics USD 1.05B 215.9M 2026-06
Sanofi EUR 6.35B 806M 2026-06
Sarepta Therapeutics USD 464.45M 336.83M 2026-03
United Therapeutics USD 1.28B 277.4M 2026-03
Vanda Pharmaceuticals USD 84.85M 14.83M 2025-12